Atlas Trials

Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction

Clinical trial NCT06250894 · UNKNOWN

Trial details

NCT number
NCT06250894
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
PD-1Neoadjuvant ChemoradiotherapyGastroesophageal Junction Cancer
Start date
2021-03-30
Primary completion
2024-06-30
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.